Therapeutic advances in relapsed and refractory peripheral T-cell lymphoma
R Stuver, AJ Moskowitz - Cancers, 2023 - mdpi.com
Simple Summary T-cell lymphomas are a rare, heterogeneous family of lymphomas derived
from post-thymic T lymphocytes. For patients with relapsed or refractory disease, outcomes …
from post-thymic T lymphocytes. For patients with relapsed or refractory disease, outcomes …
Genetics abnormalities with clinical impact in primary cutaneous lymphomas
F Gallardo, RM Pujol - Cancers, 2022 - mdpi.com
Simple Summary The genetic landscape of cutaneous T-cell lymphomas analyzed by
sequencing high throughput techniques shows a heterogeneous somatic mutational profile …
sequencing high throughput techniques shows a heterogeneous somatic mutational profile …
Single-cell RNA sequencing comparison of CD4+, CD8+ and T-cell receptor γδ+ cutaneous T-cell lymphomas reveals subset-specific molecular phenotypes
S Chennareddy, K Rindler, JR Ruggiero… - British Journal of …, 2024 - academic.oup.com
Background Malignant clones of primary cutaneous T-cell lymphomas (CTCL) can show a
CD4+, CD8+ or T-cell receptor (TCR)-γδ+ phenotype, but their individual impact on tumour …
CD4+, CD8+ or T-cell receptor (TCR)-γδ+ phenotype, but their individual impact on tumour …
Classifications of cutaneous lymphomas and lymphoproliferative disorders: An update from the EORTC cutaneous lymphoma histopathology group
The classification of primary cutaneous lymphomas and lymphoproliferative disorders (LPD)
is continuously evolving by integrating novel clinical, pathological and molecular data …
is continuously evolving by integrating novel clinical, pathological and molecular data …
JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature
Simple Summary Cutaneous T-cell lymphomas (CTCLs) are a rare kind of skin cancer that
currently has no curative treatment except allogeneic stem cell transplantation. The aim of …
currently has no curative treatment except allogeneic stem cell transplantation. The aim of …
Tyrosine kinases in nodal peripheral T-cell lymphomas
PP Piccaluga, C Cascianelli, G Inghirami - Frontiers in Oncology, 2023 - frontiersin.org
Nodal peripheral T-cell lymphomas (PTCL) are uncommon and heterogeneous tumors
characterized by a dismal prognosis. Targeted therapy has been proposed. However …
characterized by a dismal prognosis. Targeted therapy has been proposed. However …
Molecular techniques drive cutting edge advancements in management of cutaneous T cell lymphoma
MN Lefebvre, N Borcherding, RJ Reis, E Mou… - Frontiers in …, 2023 - frontiersin.org
Cutaneous 5T cell lymphoma (CTCL), characterized by malignant T cells infiltrating the skin
with potential for dissemination, remains a challenging disease to diagnose and treat due to …
with potential for dissemination, remains a challenging disease to diagnose and treat due to …
Advances in the understanding and treatment of Cutaneous T-cell Lymphoma
FS Bakr, SJ Whittaker - Frontiers in Oncology, 2022 - frontiersin.org
Cutaneous T-cell lymphomas (CTCL) are a heterogeneous group of non-Hodgkin's
lymphomas (NHL) characterised by the clonal proliferation of malignant, skin homing T-cells …
lymphomas (NHL) characterised by the clonal proliferation of malignant, skin homing T-cells …
[HTML][HTML] Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: pathogenetic insights and translational implications
MA Wasik, PM Kim, R Nejati - Frontiers in Oncology, 2024 - frontiersin.org
While normal B-and T-lymphocytes require antigenic ligands to become activated via their B-
and T-cell receptors (BCR and TCR, respectively), B-and T-cell lymphomas show the broad …
and T-cell receptors (BCR and TCR, respectively), B-and T-cell lymphomas show the broad …
[HTML][HTML] Clinical Validation of FusionPlex RNA Sequencing and Its Utility in the Diagnosis and Classification of Hematologic Neoplasms
X Chen, W Wang, J Yeh, Y Wu, VG Oehler… - The Journal of Molecular …, 2023 - Elsevier
Recurrent gene rearrangements result in gene fusions that encode chimeric proteins, driving
the pathogenesis of many hematologic neoplasms. The fifth edition World Health …
the pathogenesis of many hematologic neoplasms. The fifth edition World Health …